Erratum (DOI:10.1016/j.transproceed.2008.03.161);Exendin-4 Does Not Promote Beta-Cell Proliferation or Survival During the Early Post-Islet Transplant Period in Mice

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1650-1657

  Crutchlow, M F ^a   Yu, M ^a   Bae, Y S ^a   Deng, S ^a   Stoffers, D A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; IMMUNOSUPPRESSIVE AGENT; STREPTOZOCIN;

ADOLESCENT; ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; BODY WEIGHT; CELL DEATH; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; ENGRAFTMENT; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT FAILURE; HYPOGLYCEMIA; HYPOXIA; INSULIN DEPENDENCE; KIDNEY CAPSULE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 45449110019     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.08.081     Document Type: Erratum

References (50)

1. Baggio L., Adatia F., Bock T., et al. Sustained expression of exendin-4 does not perturb glucose homeostasis, beta-cell mass, or food intake in metallothionein-preproexendin transgenic mice. J Biol Chem 275 (2000) 34471
2. Baggio L.L., and Drucker D.J. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2. Best Pract Res Clin Endocrinol Metab 18 (2004) 531
3. Baggio L.L., Kim J.G., and Drucker D.J. Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo. Diabetes 53 suppl 3 (2004) S205
4. Blume N., Skouv J., Larsson L.I., et al. Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. J Clin Invest 96 (1995) 2227
5. Brandt A., Katschinski M., Arnold R., et al. GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve. Am J Physiol Endocrinol Metab 281 (2001) E242
6. Buse J.B., Henry R.R., Han J., et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care 27 (2004) 2628
7. Contreras J.L., Eckstein C., Smyth C.A., et al. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 53 (2004) 2804
8. Contreras J.L., Eckstein C., Smyth C.A., et al. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 52 (2003) 2935
9. D'Amico E., Hui H., Khoury N., et al. Pancreatic beta-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs. J Mol Endocrinol 34 (2005) 377
10. Davalli A.M., Scaglia L., Zangen D.H., et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45 (1996) 1161
11. DeFronzo R.A., Ratner R.E., Han J., et al. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 28 (2005) 1092
12. Delmeire D., Flamez D., Moens K., et al. Prior in vitro exposure to GLP-1 with or without GIP can influence the subsequent beta cell responsiveness. Biochem Pharmacol 68 (2004) 33
13. Duvivier-Kali V.F., Omer A., Parent R.J., et al. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50 (2001) 1698
14. Eckhoff D.E., Eckstein C., Smyth C.A., et al. Enhanced isolated pancreatic islet recovery and functionality in rats by 17beta-estradiol treatment of brain death donors. Surgery 136 (2004) 336
15. Edwards C.M., Todd J.F., Ghatei M.A., et al. Subcutaneous glucagon-like peptide-1 (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects. Clin Sci (Lond) 95 (1998) 719
16. Farilla L., Hui H., Bertolotto C., et al. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143 (2002) 4397
17. Fernandes J.R., Duvivier-Kali V.F., Keegan M., et al. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors. Transpl Immunol 13 (2004) 191
18. Fineman M.S., Bicsak T.A., Shen L.Z., et al. Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes. Diabetes Care 26 (2003) 2370
19. Gaglia J.L., Shapiro A.M., and Weir G.C. Islet transplantation: progress and challenge. Arch Med Res 36 (2005) 273
20. Garcia-Ocana A., Vasavada R.C., Cebrian A., et al. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 50 (2001) 2752
21. Hahn H.J., Dunger A., Laube F., et al. Reversibility of the acute toxic effect of cyclosporin A on pancreatic B cells of Wistar rats. Diabetologia 29 (1986) 489
22. Hirano Y., Fujihira S., Ohara K., et al. Morphological and functional changes of islets of Langerhans in FK506-treated rats. Transplantation 53 (1992) 889
23. Holst J.J. Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1. Diabetes Metab Res Rev 18 (2002) 430
24. Hope K.M., Tran P.O., Zhou H., et al. Regulation of alpha-cell function by the beta-cell in isolated human and rat islets deprived of glucose: the "switch-off" hypothesis. Diabetes 53 (2004) 1488
25. Hui H., Nourparvar A., Zhao X., et al. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 144 (2003) 1444
26. Ionut V., Hucking K., Liberty I.F., et al. Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones. Diabetologia 48 (2005) 967
27. Kendall D.M., Riddle M.C., Rosenstock J., et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 28 (2005) 1083
28. King A., Lock J., Xu G., et al. Islet transplantation outcomes in mice are better with fresh islets and exendin-4 treatment. Diabetologia 48 (2005) 2074
29. Lawrence M.C., Bhatt H.S., and Easom R.A. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 51 (2002) 691
30. Lawrence M.C., Bhatt H.S., Watterson J.M., et al. Regulation of insulin gene transcription by a Ca(2+)-responsive pathway involving calcineurin and nuclear factor of activated T cells. Mol Endocrinol 15 (2001) 1758
31. Li L., El-Kholy W., Rhodes C.J., et al. Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia 48 (2005) 1339
32. Li Y., Hansotia T., Yusta B., et al. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem 278 (2003) 471
33. Martinez O.M., and Rosen H.R. Basic concepts in transplant immunology. Liver Transpl 11 (2005) 370
34. Mattsson G., Jansson L., and Carlsson P.O. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 51 (2002) 1362
35. Menger M.D., Jaeger S., Walter P., et al. Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans. Diabetes 38 suppl 1 (1989) 199
36. Montana E., Bonner-Weir S., and Weir G.C. Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozotocin diabetic C57BL/6 mice. J Clin Invest 91 (1993) 780
37. Paty B.W., Ryan E.A., Shapiro A.M., et al. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 51 (2002) 3428
38. Redondo A., Trigo M.V., Acitores A., et al. Cell signalling of the GLP-1 action in rat liver. Mol Cell Endocrinol 204 (2003) 43
39. Ryan E.A., Paty B.W., Senior P.A., et al. Five-year follow-up after clinical islet transplantation. Diabetes 54 (2005) 2060
40. Scaglia L., Smith F.E., and Bonner-Weir S. Apoptosis contributes to the involution of beta cell mass in the postpartum rat pancreas. Endocrinology 136 (1995) 5461
41. Shapiro A.M., Lakey J.R., Ryan E.A., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343 (2000) 230
42. Stoffers D.A., Desai B.M., DeLeon D.D., et al. Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes 52 (2003) 734
43. Stoffers D.A., Kieffer T.J., Hussain M.A., et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49 (2000) 741
44. Toft-Nielsen M., Madsbad S., and Holst J.J. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. Diabetologia 41 (1998) 1180
45. Tourrel C., Bailbe D., Lacorne M., et al. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 51 (2002) 1443
46. Tourrel C., Bailbe D., Meile M.J., et al. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 50 (2001) 1562
47. Vajkoczy P., Menger M.D., Simpson E., et al. Angiogenesis and vascularization of murine pancreatic islet isografts. Transplantation 60 (1995) 123
48. Villanueva-Penacarrillo M.L., Puente J., Redondo A., et al. Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models. Endocrine 15 (2001) 241
49. Xu G., Stoffers D.A., Habener J.F., et al. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48 (1999) 2270
50. Zhou H., Tran P.O., Yang S., et al. Regulation of alpha-cell function by the beta-cell during hypoglycemia in Wistar rats: the "switch-off" hypothesis. Diabetes 53 (2004) 1482